Hemo Organic Statistics

Total Valuation

Hemo Organic has a market cap or net worth of INR 37.47 million. The enterprise value is 52.17 million.

Market Cap	37.47M
Enterprise Value	52.17M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Hemo Organic has 3.47 million shares outstanding. The number of shares has increased by 0.62% in one year.

Current Share Class	3.47M
Shares Outstanding	3.47M
Shares Change (YoY)	+0.62%
Shares Change (QoQ)	+0.57%
Owned by Insiders (%)	41.46%
Owned by Institutions (%)	8.08%
Float	1.95M

Valuation Ratios

The trailing PE ratio is 23.00.

PE Ratio	23.00
Forward PE	n/a
PS Ratio	1.51
PB Ratio	-24.73
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	31.83
EV / Sales	2.10
EV / EBITDA	n/a
EV / EBIT	203.81
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.29

Current Ratio	1.29
Quick Ratio	0.69
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	0.53%
Return on Invested Capital (ROIC)	1.42%
Return on Capital Employed (ROCE)	1.93%
Revenue Per Employee	4.97M
Profits Per Employee	327,800
Employee Count	5
Asset Turnover	0.82
Inventory Turnover	n/a

Taxes

Income Tax	-1.38M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.67% in the last 52 weeks. The beta is -0.05, so Hemo Organic's price volatility has been lower than the market average.

Beta (5Y)	-0.05
52-Week Price Change	+0.67%
50-Day Moving Average	10.31
200-Day Moving Average	10.79
Relative Strength Index (RSI)	59.24
Average Volume (20 Days)	1,079

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hemo Organic had revenue of INR 24.84 million and earned 1.64 million in profits. Earnings per share was 0.47.

Revenue	24.84M
Gross Profit	2.85M
Operating Income	256,000
Pretax Income	256,000
Net Income	1.64M
EBITDA	n/a
EBIT	256,000
Earnings Per Share (EPS)	0.47

Full Income Statement

Balance Sheet

The company has 87,000 in cash and 14.80 million in debt, giving a net cash position of -14.71 million or -4.24 per share.

Cash & Cash Equivalents	87,000
Total Debt	14.80M
Net Cash	-14.71M
Net Cash Per Share	-4.24
Equity (Book Value)	-1.52M
Book Value Per Share	-0.44
Working Capital	10.47M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.62M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 11.46%, with operating and profit margins of 1.03% and 6.60%.

Gross Margin	11.46%
Operating Margin	1.03%
Pretax Margin	1.03%
Profit Margin	6.60%
EBITDA Margin	n/a
EBIT Margin	1.03%
FCF Margin	n/a

Dividends & Yields

Hemo Organic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.62%
Shareholder Yield	n/a
Earnings Yield	4.37%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hemo Organic has an Altman Z-Score of 0.2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.2
Piotroski F-Score	3